Pasithea Therapeutics

Three more biotechs hit Nasdaq as the sector, now with more than $13B raised, continues barreling toward record
Endpoints
Wed, 09/15/21 - 10:56 am
IPOs
SPACs
NASDAQ
Pasithea Therapeutics
Tyra Biosciences
DiCE Therapeutics